|
Age in years, mean (SD)
|
82.5 (± 6.8)
|
|
Woman, n (%)
|
59 (49%)
|
|
Cohabiting with family or others, n (%)
|
62 (51%)
|
|
Co-morbidities
|
n (%)
|
|
Hypertension
|
76 (63%)
|
|
MI / ischemic heart disease
|
62 (51%)
|
|
Atrial fibrillation
|
59 (49%)
|
|
Diabetes without complications
|
26 (22%)
|
|
Stroke
|
24 (20%)
|
|
COPD
|
20 (17%)
|
|
Renal failure
|
18 (15%)
|
|
Malignancy
|
16 (13%)
|
|
Other
|
14 (12%)
|
|
Period of time since diagnosed
|
n (%)
|
|
< 1 year
|
44 (36%)
|
|
1–5 years
|
33 (27%)
|
|
> 5 years
|
38 (31%)
|
|
Pharmacological treatment at discharge
|
n (%)
|
|
ACEI/ARB
|
91 (75%)
|
|
MRA
|
34 (28%)
|
|
Beta-blocker
|
100 (83%)
|
|
Total number of medication at discharge mean (SD)
|
11.58 (± 4.37)
|
